Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence (Q34366802)

1 August 2017

title

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence (English)

1 reference

1 August 2017

0 references

Jacques Le Houezec

1 reference

1 August 2017

Henri-Jean Aubin

series ordinal

1 reference

1 August 2017

language of work or name

English

0 references

publication date

26 August 2013

1 reference

Expert Opinion on Pharmacotherapy

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

1959-1967

1 reference

Avoidable global cancer deaths and total deaths from smoking

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Mortality in relation to smoking: 50 years' observations on male British doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Should smokers be offered assistance with stopping?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

The global research neglect of unassisted smoking cessation: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

The inverse impact law of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

The return on investment of a Medicaid tobacco cessation program in Massachusetts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Improving access to smoking cessation services for disadvantaged groups: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Monoamine oxidase inhibition for tobacco pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

An updated algorithm for choosing among smoking cessation treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

'Vaping' profiles and preferences: an online survey of electronic cigarette users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Update on pharmacologic options for smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Advances in pharmacotherapy for tobacco dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Effects of nicotine mouth spray on urges to smoke, a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

The use of bupropion SR in cigarette smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Bupropion for the treatment of nicotine withdrawal and craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Effects of gender on relapse prevention in smokers treated with bupropion SR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Suicidal behavior and depression in smoking cessation treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

A preliminary benefit-risk assessment of varenicline in smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Varenicline: the newest agent for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Placebo-controlled trial of cytisine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Vaccines against nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Differential involvement of glutamatergic mechanisms in the cognitive and subjective effects of smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Topiramate in the treatment of substance-related disorders: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

A Systematic Review of Modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

A placebo-controlled trial of modafinil for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Tobacco, nicotine and harm reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Smokeless Tobacco as a Nicotine Delivery Device: Harm or Harm Reduction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

The future of the nicotine-addiction market

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Smoking, quitting, and psychiatric disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Electronic nicotine delivery systems: a research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Effect of Nicotine Replacement on the Cigarette Withdrawal Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

Tolerability and safety of sustained-release bupropion in the management of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.818978

10.1517/14656566.2013.818978

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference